Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
暂无分享,去创建一个
Kyunga Kim | J. Park | Sung Joo Kim | H. Jang | Jung Eun Lee | W. Huh | H. Oh | Heejin Yoo | S. Son
[1] G. Knoll,et al. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis , 2015, BMJ : British Medical Journal.
[2] T. van Gelder. What Is the Future of Generics in Transplantation? , 2015, Transplantation.
[3] C. Ahn,et al. Therapeutic equivalence and pharmacokinetics of generic tacrolimus formulation in de novo kidney transplant patients. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] T. Keough-Ryan,et al. Generic Immunosuppression in Solid Organ Transplantation: A Canadian Perspective , 2012, Transplantation.
[5] R. Alloway,et al. Immunosuppression, Generic Drugs and the FDA , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[7] Zhaohui J. Cai,et al. Pretreatment data is highly predictive of liver chemistry signals in clinical trials , 2012, Drug design, development and therapy.
[8] E. Tichy,et al. A Multicenter Experience With Generic Tacrolimus Conversion , 2011, Transplantation.
[9] A. Humar,et al. The Impact of Conversion From Prograf to Generic Tacrolimus in Liver and Kidney Transplant Recipients With Stable Graft Function , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] A. Tucker,et al. A survey to determine the views of renal transplant patients on generic substitution in the UK , 2011, Transplant international : official journal of the European Society for Organ Transplantation.
[11] J. Morais,et al. The new European Medicines Agency guideline on the investigation of bioequivalence. , 2010, Basic & clinical pharmacology & toxicology.
[12] P. Corris,et al. Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[13] K. Huh,et al. A 6-month, multicenter, single-arm pilot study to evaluate the efficacy and safety of generic tacrolimus (TacroBell) after primary renal transplantation. , 2009, Transplantation proceedings.
[14] J. Weinman,et al. Assessing lay beliefs about generic medicines: Development of the generic medicines scale , 2009, Psychology, health & medicine.
[15] F. Dobbels,et al. Nonadherence Consensus Conference Summary Report , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] J. Till,et al. Inflation Targets Versus International Monetary Integration - a Canadian Perspective , 2002, SSRN Electronic Journal.
[18] P. Roderick,et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review , 2004, Transplantation.
[19] S. Takemoto,et al. Report of the American Society of Transplantation Conference on Immunosuppressive Drugs and the Use of Generic Immunosuppressants , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] Sin-Ho Jung,et al. Chi-Square Test for R×CContingency Tables with Clustered Data , 2003, Journal of biopharmaceutical statistics.
[21] H. Kohli,et al. Impact of cyclosporine withdrawal on living related renal transplants: a single-center experience. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] B. Kasiske,et al. Payment for immunosuppression after organ transplantation , 2000 .
[23] B. Kasiske,et al. Payment for immunosuppression after organ transplantation. American Society of Transplantation. , 2000, JAMA.
[24] W. H. Barr,et al. Drug substitution in transplantation: a National Kidney Foundation White Paper. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] B. Banahan,et al. A physician survey on generic drugs and substitution of critical dose medications. , 1997, Archives of internal medicine.
[26] Niels Keiding,et al. Statistical Models Based on Counting Processes , 1993 .